Bubble Intelligence

Market Intelligence For The New Regime

DEXCOM INC
DXCMdexcom.com
Latest Filing: Apr 30, 2026 • 25 Total Filings
Total Assets
2026
$6.63B
Total Revenue
2026
$1.19B
Net Income
2026
$199.50M
Operating Cash Flow
2026
$525.60M
Filing Year:
2025
Only 2025 data available
Data Source:
Showing data from all document types
Filters:
competes withcompetes withcompetes withcompetes withcompetes withcompetes withcompetes withcompetes withcompetes with
DEXCOM INC
Ticker: DXCM
Medtronic
Medical device products for women's health
Major Competitor
Abbott Laboratories
Glucose monitoring devices, CGM systems
Major Competitor
MiniMed
Glucose monitoring devices, CGM systems, insulin pumps integrated with CGM
Major Competitor
Roche Diagnostics
Glucose monitoring devices, single-point finger stick devices
Major Competitor
LifeScan, Inc.
Glucose monitoring devices, single-point finger stick devices
Major Competitor
Ascensia Diabetes Care
Glucose monitoring devices, single-point finger stick devices
Major Competitor
Roche Diabetes Care
Glucose monitoring devices
Major Competitor
Abbott
CGM systems market
Major Competitor
Medtronic plc
Glucose monitoring devices, CGM systems, insulin pumps integrated with CGM
Major Competitor
React Flow
Legend:
Company
Critical Supplier
Significant Supplier
Standard Supplier
Major Competitor
Emerging Competitor
Competitor